UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 24, 2014
PFIZER INC.
(Exact name of registrant as specified in its charter)
Delaware
1-3619
13-5315170
(State or other Jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
235 East 42nd Street
New York, New York
(Address of principal executive offices)
10017
(Zip Code)
Registrant's telephone number, including area code:
(212) 733-2323
Not Applicable
(Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the obligation of the registrant under any of the
following provisions:
[ ] Written communication pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07
Submission of Matters to a Vote of Security Holders
(a) Pfizer’s Annual Meeting of Shareholders was held on April 24, 2014.
(b) Shareholders voted on the matters set forth below.
1. The nominees for election to the Board of Directors were elected, each for a one-year term, based upon the following votes:
Nominee
Votes For
Votes Against
Abstentions
Broker non-votes
Dennis A. Ausiello
4,429,512,835
42,224,116
16,411,177
869,037,171
W. Don Cornwell
4,249,141,223
222,240,877
16,776,345
869,037,171
Frances D. Fergusson
4,415,014,133
57,256,348
15,890,675
869,037,171
Helen H. Hobbs
4,435,017,252
37,850,299
15,295,402
869,037,171
Constance J. Horner
4,377,963,784
94,141,776
16,054,899
869,037,171
James M. Kilts
4,380,011,462
88,098,189
20,054,201
869,037,171
George A. Lorch
4,420,010,648
51,225,218
16,926,258
869,037,171
Shantanu Narayen
4,429,305,816
41,670,510
17,184,262
869,037,171
Suzanne Nora Johnson
4,400,824,085
67,960,352
19,370,519
869,037,171
Ian C. Read
4,321,012,579
129,821,886
37,324,299
869,037,171
Stephen W. Sanger
4,400,496,417
65,959,599
21,704,215
869,037,171
Marc Tessier-Lavigne
4,434,264,521
33,986,253
19,908,404
869,037,171
2. The proposal to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2014 was approved based upon the following votes:
Votes for approval
5,265,709,410
71,855,336
19,635,794
N/A
Votes against
Abstentions
Broker non-votes
3. The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:
Votes for approval
4,242,933,314
Votes against
195,788,864
Abstentions
49,430,064
Broker non-votes
869,037,171
4. The proposal to approve the Pfizer Inc. 2014 Stock Plan was approved based upon the following votes:
Votes for approval
3,931,323,904
Votes against
527,114,639
Abstentions (Have the same effect as a vote against this proposal under New York Stock Exchange rules)
29,724,403
Broker non-votes
869,037,171
5. The shareholder proposal regarding the approval of political contributions policy was not approved based upon the following votes:
Votes for approval
157,446,437
Votes against
4,149,806,529
Abstentions
180,877,128
Broker non-votes
869,037,171
6. The shareholder proposal regarding lobbying activities was not approved based upon the following votes:
Votes for approval
267,720,617
Votes against
4,027,091,452
Abstentions
193,329,820
Broker non-votes
869,037,171
7. The shareholder proposal regarding action by written consent was not approved based upon the following votes: